期刊
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
卷 368, 期 1626, 页码 -出版社
ROYAL SOC
DOI: 10.1098/rstb.2012.0504
关键词
endogenous retroviruses; HERV-K; pathogenesis; pathophysiology
类别
资金
- Marie Curie Intra-European Fellowship (European Commission)
- Medical Research Council Clinician Scientist Fellowship
- Wellcome Trust
- Royal Society
- Medical Research Council [MR/K010565/1] Funding Source: researchfish
- MRC [MR/K010565/1] Funding Source: UKRI
Almost 8% of the human genome comprises endogenous retroviruses (ERVs). While they have been shown to cause specific pathologies in animals, such as cancer, their association with disease in humans remains controversial. The limited evidence is partly due to the physical and bioethical restrictions surrounding the study of transposons in humans, coupled with the major experimental and bioinformatics challenges surrounding the association of ERVs with disease in general. Two biotechnological landmarks of the past decade provide us with unprecedented research artillery: (i) the ultra-fine sequencing of the human genome and (ii) the emergence of high-throughput sequencing technologies. Here, we critically assemble research about potential pathologies of ERVs in humans. We argue that the time is right to revisit the long-standing questions of human ERV pathogenesis within a robust and carefully structured framework that makes full use of genomic sequence data. We also pose two thought-provoking research questions on potential pathophysiological roles of ERVs with respect to immune escape and regulation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据